Somewhat suddenly, Boston University’s school of medicine has in hand 12,024 applications from students hoping to become MDs. It only has 110 seats. Across the country, Stanford has 11,000 applicants for 90 openings.
People tend to perceive themselves as less swayed than others by COVID-19 misinformation, and the gap helps explain why some people are more open than others to governmental interventions.
The COVID crisis has pushed healthcare providers to up their game on digital health, but the sector is not moving fast enough on this front for the liking of healthcare consumers.
More than 105 exhibitors presented AI-specific wares in the virtual AI showcase. That was down from 2019’s pre-COVID 150 but still easily beat 2018’s head count, around 75.
An Ohio-based healthcare AI company focused on improving fiscal performance for payers as well as providers is buying a like-minded entity with expertise in streamlining prior-authorization processes.
Drawing on nothing more than Facebook activity, psychiatric AI can distinguish individuals headed for hospitalization with schizophrenia from those with worsening mood disorders such as clinical depression and bipolar states.
As is so often the case with COVID-19, the numbers sketch out a dauntingly vast landscape while the anecdotes paint portraits of affected human denizens.
Some 501 accountable care organizations and other provider entities are urging Congressional leadership of both parties to modify the “unrealistic threshold tests” set out in the 2021 edition of the bipartisan Medicare Access and CHIP Reauthorization Act (MACRA) of 2015.
